Heroin addiction is a serious problem and the relapse rate of existing treatment methods is extremely high. Recently, international journals such as Science reported that repetitive transcranial magnetic stimulation (rTMS) can reduce the craving of addicts, alleviate depression and anxiety symptoms, and is expected to become an effective treatment. Our preliminary experiment using rTMS to stimulate the left dorsolateral prefrontal cortex of heroin addicts also showed similar effects, however, the mechanism is unclear. Previously, the investigators found that the functional connectivity between left executive control network and default mode network was negatively correlated relapse behavior, while the functional connectivity between salience network and default mode network was positively correlated with relapse behavior. Studies have shown that dopamine dysfunction in addicts and brain metabolism is the biological basis of network connectivity. It suggests that elucidating the relationship between the characteristics of large brain network connectivity and the level of dopamine receptor and relapse behavior in addicts is hopeful to further understand the neurological mechanism of rTMS treatment for addiction. In this project, the investigators intend to observe the changes of brain network connectivity, glucose metabolism and dopamine D2 receptor before and after rTMS treatment in addicts from the perspective of large brain network by combining PET/MRI with psychobehavioral approach. The relationship between rTMS and relapse behavior will be deeply analyzed to provide scientific basis for the development of effective treatment programs.
Age range
25 Years – 55 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change of craving
Timeframe: Baseline, 1 week later, 1,2,3,4,5,6 months later
Change of protracted-abstinence symptoms
Timeframe: Baseline, 1 week later, 1,2,3,4,5,6 months later
Change of depress symptoms
Timeframe: Baseline, 1 week later, 1,2,3,4,5,6 months later
Change of anxiety symptoms
Timeframe: Baseline, 1 week later, 1,2,3,4,5,6 months later
Change of impulsive behaviors
Timeframe: Baseline, 1 week later, 1,2,3,4,5,6 months later
Change of sleep
Timeframe: Baseline, 1 week later, 1,2,3,4,5,6 months later
Change of functional connectivity between dorsolateral prefrontal cortex and whole brain
Timeframe: Baseline, 1 week later, 1,3,6 months later
Change of gray matter volume of whole brain
Timeframe: Baseline, 1 week later, 1,3,6 months later
Change of white matter integrity of whole brain
Timeframe: Baseline, 1 week later, 1,3,6 months later
Change of availability of dopamine 2 receptor of whole brain
Timeframe: Baseline, 1 month later
Change of metabolism of glucose in the brain
Timeframe: Baseline, 1 month later